Stipple Bio Funding: $100M Raised, Series A (2025)
Stipple Bio is a Biotech company based in Cambridge, Massachusetts. It has raised $100M in total funding. Latest round: Series A.
Stipple Bio funding overview
Stipple Bio is a Biotech company based in Cambridge, Massachusetts. Stipple Bio has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Stipple Bio runs through 2025; nothing later has been disclosed. Investors on record include RA Capital Management, Nextech Invest, a16z Bio + Health. 3 distinct backers are named across the disclosed rounds.
Stipple Bio at a glance
Total raised
$100M
Latest round
Series A
Latest round date
January 2025
Industry
Biotech
Headquarters
Cambridge, Massachusetts
Notable investors
RA Capital Management, Nextech Invest, a16z Bio + Health
Frequently asked about Stipple Bio funding
How much has Stipple Bio raised?
Stipple Bio has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Stipple Bio?
RA Capital Management, Nextech Invest, a16z Bio + Health are named among the investors backing Stipple Bio.
What was the latest Stipple Bio funding round?
The most recent disclosed round is a Series A, announced in January 2025.
Where is Stipple Bio based?
Stipple Bio is based in Cambridge, Massachusetts.
What sector does Stipple Bio operate in?
Stipple Bio is tracked under Biotech from Cambridge, Massachusetts, with $100M in disclosed funding.
When did Stipple Bio last raise?
The last disclosed Stipple Bio round closed in January 2025 at Series A.
Totals shown for Stipple Bio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Cambridge and the investors behind them below.
